One billion fewer hydrocodone combination tablets were dispensed and 26.3 million fewer prescriptions were written after the Drug Enforcement Administration enacted tighter controls on prescribing these products, a new study finds.
More than three-quarters of dentists in the United States ask their patients about illicit drug use, a new survey finds. However, only 54 percent say such drug screening should be their responsibility.
A new analysis of Medicare’s prescription drug program finds generic Vicodin was the most widely prescribed drug in 2013, according to The Wall Street Journal. More than half of the prescriptions came from family practice or internal medicine doctors.
The Drug Enforcement Administration has announced it will reclassify hydrocodone combination products such as Vicodin. Under the new rules, patients will be able to receive the drugs for only up to 90 days without receiving a new prescription, The Wall Street Journal reports.
The Food and Drug Administration’s decision to approve Zohydro ER (extended release), a pure form of the painkiller hydrocodone, has stirred opposition from many addiction medicine experts, public health officials and legislators. Join Together spoke with Dr. Richard Blondell, Vice Chair for Addiction Medicine in the State University of New York at Buffalo Department of Family Medicine, about the issue.
The pure hydrocodone drug Zohydro ER (extended release) will be banned in Massachusetts, Governor Deval Patrick has announced. He cited a public health emergency stemming from opioid abuse, Reuters reports.
The maker of OxyContin announced promising results from a study of a tamper-resistant form of hydrocodone, The Washington Post reports. The Food and Drug Administration has been criticized for approving Zohydro ER (extended release), a pure form of hydrocodone that is not tamper-resistant.
West Virginia Senator Joe Manchin this week called on Health and Human Services Secretary Kathleen Sebelius to overrule the Food and Drug Administration’s decision to approve the pure hydrocodone drug Zohydro ER (extended release).
More than 40 addiction treatment, health care and consumer groups are urging the Food and Drug Administration to reverse its decision to approve the prescription painkiller Zohydro ER (extended release), CNN reports.
The attorneys general from 28 states are asking the Food and Drug Administration (FDA) to reassess its decision to approve Zohydro ER (extended release), a pure form of the painkiller hydrocodone. Earlier this month, four U.S. senators told the FDA Commissioner Margaret Hamburg they disagree with the agency’s decision to approve the drug.
A study of opioid-dependent patients entering drug-treatment programs across the country finds oxycodone is the most popular prescription opioid to abuse because of the quality of the high the drug produces.
Last June, I testified before a Reference Committee at the annual meeting of the American Medical Association, explaining a resolution that American Society of Addiction Medicine had brought forward to encourage the Food and Drug Administration to reschedule hydrocodone combination products from Schedule III to Schedule II. I expected there to be few others testifying. I wasn’t at all ready for the long line of individuals standing at the “con” microphone, ready to speak against the resolution, says Dr. Stuart Gitlow, ASAM President.
The Food and Drug Administration on Friday approved the first pure hydrocodone drug in the United States. The drug, Zohydro ER (extended release), was approved for patients with pain that requires daily, around-the-clock, long-term treatment that cannot be treated with other drugs.
Business and patient groups waged a costly lobbying campaign against tighter prescribing regulations for hydrocodone products for many years, according to The New York Times. Last week, the Food and Drug Administration recommended tighter restrictions for products containing hydrocodone and other painkillers such as acetaminophen or aspirin.
The Food and Drug Administration has recommended tighter restrictions for products containing hydrocodone and other painkillers such as acetaminophen or aspirin. These combination products include Vicodin and Lortab.
The death rate from opiate overdoses among Veterans Affairs patients is almost double the national average, according to a report by the Center for Investigative Reporting. Prescriptions for hydrocodone, oxycodone, methadone and morphine have jumped 270 percent in the past 12 years among VA patients, the report found.
Kentucky Governor Steve Beshear announced this week that the number of doses of opioid painkillers that were prescribed in the state have dropped in the last year, since he signed a new law designed to cut down on prescription drug abuse.
A bipartisan group of legislators introduced a bill that would tighten restrictions on hydrocodone, the Los Angeles Times reports. The Safe Prescribing Act of 2013 follows recommendations made in January by a Food and Drug Administration advisory panel.
The Food and Drug Administration told lawmakers this month that the process of reclassifying hydrocodone combination products, in order to make them more difficult to prescribe, will be long, The Hill reports.
A Food and Drug Administration (FDA) advisory panel voted Friday to strengthen restrictions on hydrocodone combination drugs, such as Vicodin. The panel recommended that the FDA make the drugs more difficult to prescribe.